Critical Review: Enovis (NYSE:ENOV) and Advanced Biomedical Technologies (OTCMKTS:ABMT)
Critical Review: Enovis (NYSE:ENOV) and Advanced Biomedical Technologies (OTCMKTS:ABMT)
Enovis (NYSE:ENOV – Get Rating) and Advanced Biomedical Technologies (OTCMKTS:ABMT – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.
Enovis(NYSE：ENOV-GET Rating)和Advanced Biomedical Technologies(OTCMKTS：ABMT-GET Rating)都是醫療公司，但哪一家是更好的投資？我們將根據兩家公司的收益、股息、估值、分析師建議、機構持股、風險和盈利能力等方面的實力進行比較。
Analyst Recommendations
分析師建議
This is a breakdown of current recommendations for Enovis and Advanced Biomedical Technologies, as reported by MarketBeat.
據MarketBeat報道，這是對Enovis和先進生物醫學技術的當前建議的細分。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Enovis | 0 | 2 | 1 | 0 | 2.33 |
| Advanced Biomedical Technologies | 0 | 0 | 0 | 0 | N/A |
| 銷售評級 | 保持評級 | 購買評級 | 強勁的買入評級 | 評級分數 | |
| 伊諾維斯 | 0 | 2 | 1 | 0 | 2.33 |
| 先進生物醫學技術 | 0 | 0 | 0 | 0 | 不適用 |
Enovis currently has a consensus price target of $67.00, suggesting a potential upside of 16.12%. Given Enovis' higher possible upside, research analysts clearly believe Enovis is more favorable than Advanced Biomedical Technologies.
Enovis目前的普遍目標價為67.00美元，這意味着潛在的上漲幅度為16.12%。考慮到Enovis更有可能的上行空間，研究分析師顯然認為Enovis比Advanced Biomedical Technologies更有利。
Profitability
盈利能力
| Net Margins | Return on Equity | Return on Assets | |
| Enovis | 1.77% | 6.35% | 3.57% |
| Advanced Biomedical Technologies | N/A | N/A | N/A |
| 淨利潤率 | 股本回報率 | 資產回報率 | |
| 伊諾維斯 | 1.77% | 6.35% | 3.57% |
| 先進生物醫學技術 | 不適用 | 不適用 | 不適用 |
Risk and Volatility
風險和波動性
Enovis has a beta of 2.18, meaning that its stock price is 118% more volatile than the S&P 500. Comparatively, Advanced Biomedical Technologies has a beta of -1, meaning that its stock price is 200% less volatile than the S&P 500.
Enovis的貝塔係數為2.18，這意味着其股價的波動性比標準普爾500指數高118%。相比之下，Advanced Biomedical Technologies的貝塔係數為-1，這意味着其股價的波動性比標準普爾500指數低200%。
Earnings & Valuation
收益與估值
This table compares Enovis and Advanced Biomedical Technologies' top-line revenue, earnings per share and valuation.
此表比較了Enovis和Advanced Biomedical Technologies的營收、每股收益和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Enovis | $3.85 billion | 0.81 | $71.66 million | $1.32 | 43.71 |
| Advanced Biomedical Technologies | $120,000.00 | 35.88 | -$670,000.00 | N/A | N/A |
| 總收入 | 價格/銷售額比 | 淨收入 | 每股收益 | 市盈率 | |
| 伊諾維斯 | 38.5億美元 | 0.81 | 7166萬美元 | $1.32 | 43.71 |
| 先進生物醫學技術 | $120,000.00 | 35.88 | -$670,000.00 | 不適用 | 不適用 |
Enovis has higher revenue and earnings than Advanced Biomedical Technologies.
Enovis的收入和收益高於Advanced Biomedical Technologies。
Summary
摘要
Enovis beats Advanced Biomedical Technologies on 8 of the 9 factors compared between the two stocks.
在兩隻股票比較的9個因素中，Enovis有8個擊敗了Advanced Biomedical Technologies。
About Enovis
關於Enovis
(Get Rating)
(獲取評級)
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Enovis公司是一家全球性的醫療技術公司。該公司開發、製造和分銷醫療器械產品，供整形外科專家、外科醫生、初級保健醫生、疼痛管理專家、物理治療師、足科醫生、脊椎按摩師、運動訓練師和其他醫療保健專業人員使用，以治療因退行性疾病、畸形、創傷事件和運動相關傷害而導致的肌肉骨骼疾病患者。它提供堅硬和柔軟的矯形支撐、冷熱治療產品、骨生長刺激器、血管治療系統和加壓服裝、治療鞋和襯墊、用於疼痛管理的電刺激器和物理治療產品；以及一套用於髖關節、膝部、肩部、肘部、足部、腳踝和手指的重建關節產品。Enovis Corporation通過醫療保健專業人員、消費者零售店和藥店等獨立分銷商銷售其產品，並直接以DJO品牌銷售。該公司的前身是科爾法克斯公司。Enovis公司總部設在特拉華州威爾明頓。
About Advanced Biomedical Technologies
關於先進的生物醫學技術
(Get Rating)
(獲取評級)
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.
高級生物醫學技術公司是一家處於發展階段的公司，設計、開發、製造和銷售生物材料內固定設備。它提供聚合物骨接合設備，如外科螺絲、捆綁鋼絲、棒和相關醫療設備，用於治療骨科創傷、與運動相關的醫療、軟骨修復和相關治療，以及重建牙科程序。該公司前身為Geostar礦業公司，並於2009年3月更名為Advanced Biomedical Technologies，Inc.。先進生物醫學技術公司成立於2002年，總部設在紐約。
Receive News & Ratings for Enovis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovis and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Enovis Daily》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Enovis和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。